Cargando…
Targeting Phosphorylcholine in Established Atherosclerosis?
[Figure: see text]
Autor principal: | Tsiantoulas, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188919/ https://www.ncbi.nlm.nih.gov/pubmed/32369044 http://dx.doi.org/10.1016/j.jacbts.2020.03.005 |
Ejemplares similares
-
Atherosclerosis at your fingertips?
por: Swenne, C.A.
Publicado: (2015) -
Antibodies against Native and Oxidized Cardiolipin and Phosphatidylserine and Phosphorylcholine in Atherosclerosis Development
por: Frostegård, Anna G., et al.
Publicado: (2014) -
Phosphorylcholine-Primed Dendritic Cells Aggravate the Development of Atherosclerosis in ApoE(−/−) Mice
por: Dong, Qian, et al.
Publicado: (2021) -
Non-Alcoholic Fatty Liver Disease, a Marker of Subclinical Atherosclerosis Applicable Only to Metabolic Syndrome?: Time to Organize the Connection between Metabolism and Atherosclerosis
por: Lee, Seung-Pyo
Publicado: (2012) -
Subclinical atherosclerosis: A hidden threat for patients with ankylosing spondylitis
por: Hamdi, Wafa, et al.
Publicado: (2019)